Report
Eurofins : Q3 on the weak side, revenue guidance cut, but margin/FCF guidance maintained. The cash audit is positive for Eurofins
>Q3: below expectations on the top line, curbed by a deceleration in biopharma - Eurofins this morning reported Q3 revenue of € 1,723m, up 7.0%, falling short of our estimate (€ 1,771m) and the Visible Alpha consensus (€ 1,751m). Organic growth came in at 4.4%, undershooting expectations (ODDO 6.7%e / VA css 6.5%). The gap with our estimates is attributable mainly to the Biopharma division, where several contracts expired at the start of 2024 and have not been renewe...
Underlying
Eurofins Scientific Societe Europeenne
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Geoffroy Michalet
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.